Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Immune Response”

1,184 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,184 results

Not applicableStudy completedNCT03653676
What this trial is testing

Sickle Cell Pro-Inflammatory Response to Interval Training Study

Who this might be right for
Sickle Cell Disease
Ann & Robert H Lurie Children's Hospital of Chicago 110
Testing effectiveness (Phase 2)Study completedNCT03406468
What this trial is testing

Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung Cancer

Who this might be right for
Non-Small Cell Carcinoma of Lung, TNM Stage 4
Maastricht Radiation Oncology 36
Not applicableStudy completedNCT01472627
What this trial is testing

Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 11
Testing effectiveness (Phase 2)UnknownNCT00979160
What this trial is testing

Evaluation of Response of Dasatinib to Treat Mastocytosis

Who this might be right for
Systemic Mastocytosis
Federico II University 30
Not applicableUnknownNCT03253146
What this trial is testing

The Role and Mechanism of Vimentin in Sepsis Patients

Who this might be right for
Sepsis
Peking Union Medical College Hospital 200
Not applicableLooking for participantsNCT05444712
What this trial is testing

Transplantation After Complete Response In Patients With T-cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Hospices Civils de Lyon 204
Not applicableStudy completedNCT00357071
What this trial is testing

Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases

Who this might be right for
Eye Diseases
National Eye Institute (NEI) 219
Very early researchStudy completedNCT01666353
What this trial is testing

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

Who this might be right for
MelanomaRenal Cell Carcinoma (RCC)Non-small Cell Lung Cancer (NSCLC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableTemporarily pausedNCT04219475
What this trial is testing

Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients

Who this might be right for
Glioblastoma
OncoHost Ltd. 1,000
Testing effectiveness (Phase 2)Study completedNCT00353977
What this trial is testing

Accelerated Immunization to Induce Cytomegalovirus Immunity in Stem Cell Donors

Who this might be right for
Cytomegalovirus Infections
National Heart, Lung, and Blood Institute (NHLBI) 38
Large-scale testing (Phase 3)WithdrawnNCT07492875
What this trial is testing

Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia

Who this might be right for
Community-Acquired Pneumonia (CAP)Acute Respiratory Distress Syndrome (ARDS)Sepsis+2 more
ImmunityBio, Inc.
Not applicableUnknownNCT05243381
What this trial is testing

Inflammation, NK Cells, Antisense Protein and Exosomes, and Correlation With Immune Response During HIV Infection

Who this might be right for
HIV Infections
University Hospital, Montpellier 60
Not applicableNot Yet RecruitingNCT07776483
What this trial is testing

Personalized ctDNA Monitoring for Predicting Immunotherapy Outcomes in Advanced Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Non-Clear Cell Renal Cell Carcinoma
West China Hospital 67
Testing effectiveness (Phase 2)UnknownNCT03196869
What this trial is testing

The Study of Effect of Chronomodulated Chemotherapy on the Dendritic Cells Subsets in the Treatment of Advanced Nasopharyngeal Cancer

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Guiyang Medical University 128
Not applicableNot Yet RecruitingNCT06617351
What this trial is testing

This Repeated Measures Parallel-group Investigation Will Examine the Influence of Short-term Melatonin Supplementation (5mg, 3 x Day for 72 Hours) on Cellular Responses, Functional Performance and Recovery Following an Acute Bout of Dynamic Resistance Exercise in Resistance Trained Men and Women

Who this might be right for
Cell MigrationCell InvasionExercise Recovery
University of Central Florida 24
Early research (Phase 1)Ended earlyNCT00585845
What this trial is testing

Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment

Who this might be right for
Malignant Epithelial MesotheliomaAdenocarcinoma of the PancreasCarcinoma, Non-Small-Cell Lung+1 more
Anza Therapeutics, Inc. 17
Testing effectiveness (Phase 2)Looking for participantsNCT05257018
What this trial is testing

R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse

Who this might be right for
Diffuse Large B-cell Lymphoma
Fudan University 83
Post-approval studies (Phase 4)Not Yet RecruitingNCT07633613
What this trial is testing

Pharmacokinetic Study of Pembrolizumab and Its Impact on Immunity and the Tumor Microenvironment, Which May Explain the Efficacy of Post-immunotherapy Chemotherapy.

Who this might be right for
Non-Small Cell Lung Carcinoma (NSCLC)Metastatic Head and Neck Squamous Cell Carcinoma
Centre Antoine Lacassagne 110
Testing effectiveness (Phase 2)Study completedNCT01745640
What this trial is testing

Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14)

Who this might be right for
Multiple Myeloma
University Hospital, Lille 63
Post-approval studies (Phase 4)Study completedNCT00133510
What this trial is testing

Influenza Vaccine in Pediatric Transplant Subjects

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 60
Next Page